Harvill Secker has acquired Mahi Cheshire's debut Deadly Cure, an "exhilarating" thriller set in a hospital following the ferocious race between two doctors to find a breakthrough cure for cancer.
The synopsis reads: "Dr Rea Darsena is devastated when she loses out on her dream research job to her best friend and med-school rival, Dr Julia Stone. When it comes to light that Julia got the job using Rea's own cutting-edge research on a possible vaccine for cancer, Rea just can't let it go. Until finally, just after a life-changing medical discovery, Julia is found dead. Now Rea has the dream job she's always wanted, but is it one she would have been willing to kill for?"
Jade Chandler, editorial director, bought world all languages rights from Isobel Gahan at Curtis Brown. Publication is slated for April 2022.
Chandler said: "I was swept up in the drama and excitement of Deadly Cure from the pulse-pounding opening pages! Mahi has created a wonderfully page-turning plot and her day job as a doctor means she brings an excellent sense of authenticity to the characters and hospital setting. Deadly Cure is as exciting and involving as any episode of 'Grey’s Anatomy' or 'ER' and I can’t wait to share it with readers."
Cheshire, who is a GP, added: "I’m beyond delighted that Deadly Cure has found a home at Harvill Secker. Jade really gets my story and my characters and I’m so excited to be working with her and the team at Harvill Secker to bring it to life."